//
Natriuretic Peptide-Guided Heart Failure Therapy After the GUIDE-IT Study
AIM2-driven inflammasome activation in heart failure
Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure
Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes
Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction"
Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators
Cardiovascular Aging and Heart Failure: JACC Review Topic of the Week
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction